LA BioMed
18
AUG
2014

Susan D. Rubin Joins LA BioMed Leadership Team

New Research Executive Brings Wealth of Experience to Institute LOS ANGELES – (August 18, 2014) – Bringing a wealth of experience in research administration, Susan D. Rubin recently joined Los Angeles Biomedical Research Institute (LA BioMed) in a newly created role of chief...
18
AUG
2014

LA BioMed Names Six New Board Members

LOS ANGELES – (August 15, 2014) – Los Angeles Biomedical Research Institute (LA BioMed) recently named six new members to its Board of Directors, expanding the board’s expertise in the law, scientific research, engineering, development, public affairs and more. David B. Duthu,...
15
AUG
2014

The Obesity Paradox

Kamyar Kalantar-Zadeh, the world’s foremost expert on end-stage kidney disease, has followed his research to the controversial proposition that obesity might be a patient’s best friend in the hour of greatest need. Recent findings by Kalantar-Zadeh and some of his colleagues have...
21
JUL
2014

How Ayahuasca Can Revolutionize Psychotherapy

Article from Wakingtimes.com A look at the psychoactive brew that brings users a spiritual payoff for their “work” In a greenhouse at the University of Minnesota, Dennis McKenna walks past the cacao (chocolate) and the Punica (pomegranate), and strides straight to the back...
15
JUL
2014

Man up: Is testosterone an elixir of youth?

 “There’s also a problem that the ‘normal’ ranges for one laboratory may be decidedly different than they are for another laboratory,” says Ronald Swerdloff, chief endocrinologist at Harbor UCLA Medical Center in California and LA Biomed Inv....
14
JUL
2014

FDA accepts Kythera’s ATX-101 new drug application

Kythera Biopharmaceuticals’ new drug application (NDA) for its ATX-101, a submental contouring injectable drug, has been accepted for filing by the US Food and Drug Administration (FDA). According to Kythera Biopharmaceuticals, the ATX-101 NDA will be subject to a standard...
10
JUL
2014

LA Biomed: Project to provide high-quality care for patients with diabetes

Managing diabetes is a year-round challenge for anyone living with the disease. The challenge is even greater for underserved and uninsured people who often don’t have easy access to the care they need to manage their diabetes. Their inability to effectively manage their...
22
JUN
2014

Clarus Therapeutics: Phase 3 – REXTORO(R) for Men With Hypogonadism

Clarus Therapeutics, Inc., a men’s health specialty pharmaceutical company focused on the development and commercialization of REXTORO ( (Testosterone Undecanoate), an oral testosterone (T) replacement product, today presented Phase 3 clinical data from two studies that...
14
JUN
2014

Biocom/LA BioMed partners with San Diego International Airport Art Program

Biocom, the association for the Southern California life science community, and the San Diego International Airport Art Program announce the return of the cell culture exhibit, a showcase of art from microscopic research contributing to life-changing breakthroughs taking place in...

Join the mailing list

Check your email and confirm the subscription